» Articles » PMID: 14996838

Molecular Determinants of Vanilloid Sensitivity in TRPV1

Abstract

Vanilloid receptor 1 (TRPV1), a membrane-associated cation channel, is activated by the pungent vanilloid from chili peppers, capsaicin, and the ultra potent vanilloid from Euphorbia resinifera, resiniferatoxin (RTX), as well as by physical stimuli (heat and protons) and proposed endogenous ligands (anandamide, N-arachidonyldopamine, N-oleoyldopamine, and products of lipoxygenase). Only limited information is available in TRPV1 on the residues that contribute to vanilloid activation. Interestingly, rabbits have been suggested to be insensitive to capsaicin and have been shown to lack detectable [(3)H]RTX binding in membranes prepared from their dorsal root ganglia. We have cloned rabbit TRPV1 (oTRPV1) and report that it exhibits high homology to rat and human TRPV1. Like its mammalian orthologs, oTRPV1 is selectively expressed in sensory neurons and is sensitive to protons and heat activation but is 100-fold less sensitive to vanilloid activation than either rat or human. Here we identify key residues (Met(547) and Thr(550)) in transmembrane regions 3 and 4 (TM3/4) of rat and human TRPV1 that confer vanilloid sensitivity, [(3)H]RTX binding and competitive antagonist binding to rabbit TRPV1. We also show that these residues differentially affect ligand recognition as well as the assays of functional response versus ligand binding. Furthermore, these residues account for the reported pharmacological differences of RTX, PPAHV (phorbol 12-phenyl-acetate 13-acetate 20-homovanillate) and capsazepine between human and rat TRPV1. Based on our data we propose a model of the TM3/4 region of TRPV1 bound to capsaicin or RTX that may aid in the development of potent TRPV1 antagonists with utility in the treatment of sensory disorders.

Citing Articles

Neurotoxins Acting on TRPV1-Building a Molecular Template for the Study of Pain and Thermal Dysfunctions.

Beignon F, Notais M, Diochot S, Baron A, Fajloun Z, Tricoire-Leignel H Toxins (Basel). 2025; 17(2).

PMID: 39998081 PMC: 11861614. DOI: 10.3390/toxins17020064.


TRPV1 corneal neuralgia mutation: Enhanced pH response, bradykinin sensitization, and capsaicin desensitization.

Gualdani R, Barbeau S, Yuan J, Jacobs D, Gailly P, Dib-Hajj S Proc Natl Acad Sci U S A. 2024; 121(37):e2406186121.

PMID: 39226353 PMC: 11406256. DOI: 10.1073/pnas.2406186121.


Three-Dimensional Quantitative Structure-Activity Relationship Study of Transient Receptor Potential Vanilloid 1 Channel Antagonists Reveals Potential for Drug Design Purposes.

Gianibbi B, Visibelli A, Spinsanti G, Spiga O Int J Mol Sci. 2024; 25(14).

PMID: 39063195 PMC: 11276937. DOI: 10.3390/ijms25147951.


A molecular perspective on identifying TRPV1 thermosensitive regions and disentangling polymodal activation.

Luu D, Owens A, Mebrat M, Van Horn W Temperature (Austin). 2023; 10(1):67-101.

PMID: 37187836 PMC: 10177694. DOI: 10.1080/23328940.2021.1983354.


A Stable Cell Line Co-expressing hTRPV1 and GCaMP6s: A Novel Cell-based Assay For High-throughput Screening of hTRPV1 Agonists.

Shi J, Chen X, Zhang Y, Shi T, Zhang R, Zhu S Comb Chem High Throughput Screen. 2023; 27(2):298-306.

PMID: 37171000 DOI: 10.2174/1386207326666230511143259.